Insiders · DFTX

Daniel Karlin

Chief Medical Officer, Director at Definium Therapeutics, Inc. (DFTX) since January 2022

Daniel Karlin has filed 36 insider reports with the SEC since January 2022, as chief Medical Officer and director at Definium Therapeutics, Inc. (DFTX) and officer at Mind Medicine (MindMed) Inc. (MNMD). In the last 12 months Daniel Karlin sold $1.07M of stock on the open market. In the latest filing, on September 30, 2026, Daniel Karlin sold 10,853 shares of Definium Therapeutics, Inc. (DFTX) for $397K at an average of $36.57.

Filings
36
Companies
2
Bought on market
None
Sold on market
$1.6M

Companies where Daniel Karlin is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Definium Therapeutics, Inc. logo
DFTX
Definium Therapeutics, Inc.
Chief Medical Officer, Directorsince January 2022792,846$1.6M$29.48Sep 30, 2026
Mind Medicine (MindMed) Inc. logo
MNMD
Mind Medicine (MindMed) Inc.
OfficerDec 26, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Daniel Karlin.

Compare Daniel Karlin with

Other insiders at the same companies

Questions about Daniel Karlin

What is Daniel Karlin's role at Definium Therapeutics, Inc.?
Daniel Karlin reports to the SEC as chief Medical Officer and director at Definium Therapeutics, Inc. (DFTX), according to the latest filing on September 30, 2026. Daniel Karlin has also filed as officer at Mind Medicine (MindMed) Inc. (MNMD).
How many shares does Daniel Karlin own?
After the latest filing that states it, Daniel Karlin directly owned 792,846 shares of Definium Therapeutics, Inc. (DFTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Daniel Karlin bought or sold stock recently?
The most recent open-market sale was on September 25, 2026: sold 10,853 shares of Definium Therapeutics, Inc. (DFTX) for $397K at an average of $36.57.
How do I get alerts when Daniel Karlin files?
Follow Daniel Karlin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Daniel Karlin filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Daniel Karlin (SEC CIK 0001897618). Totals count each trade once, skipping amendments whose original is on file, from Jan 11, 2022 on. View on SEC EDGAR · Get this as JSON